NKTR-214

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2015-2017
0120152017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
VOLUME 36 NUMBER 5 MAY 2018 NATURE BIOTECHNOLOGY reported last November at the Society for Immunotherapy of Cancer (SITC) annual… (More)
  • table 1
Is this relevant?
2017
2017
Cytokines are potent immune modulating agents but are not ideal medicines in their natural form due to their short half-life and… (More)
Is this relevant?
2016
2016
PURPOSE Aldesleukin, recombinant human IL2, is an effective immunotherapy for metastatic melanoma and renal cancer, with durable… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
Background NKTR-214 is an immunotherapeutic drug that exerts its biological activity by binding and activating the interleukin-2… (More)
Is this relevant?